Ranbaxy Laboratories Limited, India’s largest pharmaceutical company headquartered in India, is an integrated research based international pharmaceutical company producing a wide range of quality affordable generic medicines trusted by healthcare professionals and patients across geographies. The company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances across the globe.

• Global sales of over US$ 1.6 billon.
• Amongst the top to Global Generics companies
• International revenues contribute 80% to sales.
• Robust operations in USA, Europe & Emerging Markets.
• 239 cumulative ANDA fillings with 141 approvals from US FDA.
• Strong First-to File (FTF) pipeline in USA.
• Robust Generics & innovative Research capabilities.
• Diverse product basket covering chronic & acute segments.
  
• Presence in 23 of the Top 25 Pharma markets of the world.
• Ground operations in 49 countries.
• Manufacturing facilities spread across 11 nations.
• Over 12,000 employees, 50 nationalities.

 

The joy of discovering something new. That is what drives innovation at R&D in Ranbaxy as we strive to bring value added quality generics at affordable prices. From quest to conquest arming hope with reason, we have moved up the Pharma value chain. Identifying definite opportunities from the infinite possibilities that science offers. We share your vision of an assured, healthier future for all. Let us join hands and become the world’s partners in health, healing and hope. Come, partner with us for a better tomorrow.

 

For more information, please visit:

http://www.ranbaxy.com/